Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Global Health-Hypertension in Sub-Saharan Africa

Hypertension In Sub-Saharan Africa

A Systematic Review

Juliet Addo, Liam Smeeth, David A. Leon
Download PDF
https://doi.org/10.1161/HYPERTENSIONAHA.107.093336
Hypertension. 2007;50:1012-1018
Originally published November 20, 2007
Juliet Addo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam Smeeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Leon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Hypertension is an important public health challenge worldwide. Information on the burden of disease from hypertension is essential in developing effective prevention and control strategies. An up-to-date and comprehensive assessment of the evidence concerning hypertension in sub-Saharan Africa is lacking. A literature search of the PUBMED database was conducted and supplemented by a manual search of bibliographies of retrieved articles. The search was restricted to population based studies on hypertension in sub-Saharan Africa published between January 1975 and May 2006. Data were extracted after a standard protocol and using standard data collection forms. Thirty-seven publications met the inclusion criteria. The prevalence of hypertension varied extensively between and within studies. Prevalence of hypertension was higher in urban than rural studies in all studies that covered both types of area, and also increased with increasing age in most studies. In most studies less than 40% of people with blood pressure above the defined normal range had been previously detected as hypertensive. Of people with previously diagnosed hypertension, less than 30% were on drug treatment in most studies, and less than 20% had blood pressure within the defined normal range. Hypertension is of public health importance in sub-Saharan Africa, particularly in urban areas, with evidence of considerable under-diagnosis, treatment, and control. There is an urgent need to develop strategies to prevent, detect, treat, and control hypertension effectively in the African region.

  • blood pressure
  • hypertension
  • prevalence
  • sub-Saharan Africa
  • population

Hypertension is an increasingly important medical and public health issue worldwide. High blood pressure is estimated to have caused 7.6 million premature deaths (13.5% of the total) and contributed 92 million disability-adjusted life years (DALYs) worldwide in 2001.1 In the year 2000, nonoptimal blood pressure was estimated to have caused approximately 7.1 million deaths (12.8% of the total) and contributed 64.3 million DALYs.2 It has been suggested that the prevalence of cardiovascular disease and hypertension is increasing rapidly in sub-Saharan Africa (SSA).3 The current prevalence in many developing countries, particularly in urban societies, is said to be already as high as those seen in developed countries.4,5 SSA is currently battling with communicable diseases such as malaria and HIV, and most governments in the region have limited resources and health budgets. An increasing burden of hypertension in this region is therefore likely to be of grave consequence because very few people will get treated and control is likely to be low. This in turn would result in high morbidity and mortality from potentially preventable complications such as stroke, myocardial infarction, and renal failure.

Epidemiological studies on hypertension in Africa have been conducted over the years in an attempt to estimate the burden of hypertension in this region, and these have reported variable rates within and between different population groups. The purpose of this review is to establish what reliable and comparable evidence is available on hypertension in black adults in SSA. Its aim is to assemble evidence on the prevalence and distribution of hypertension in SSA and the corresponding levels of awareness, treatment, and control.

Methods

A literature search of the PUBMED database, using the Medical subject headings “hypertension,” “blood pressure,” “Africa,” and “Africa South of the Sahara” was conducted. The search was restricted to studies in human beings published between January 1975 and May 2006. A manual search for additional studies was performed using references cited in original study articles and reviews. Additionally, studies were retrieved by searches of the World Health Organization Global Cardiovascular Infobase.6 No language restrictions were applied and publications in other languages were translated to English. Articles were incorporated into an Endnote database. Titles and abstracts were screened, and potentially relevant articles acquired. When copies of papers could not be obtained, attempts to get copies directly from the authors were made.

The eligibility criteria for inclusion were1: population based studies that included 400 or more participants aged 15 years and above2; random sampling of a defined population or studies involving entire populations3; response rate greater than 70%4; involving black participants living in sub-Saharan Africa5; standard methods of measuring blood pressure described.6 reported prevalence of hypertension (age adjusted or unadjusted)7; defined hypertension as blood pressure ≥160/95mmHg (WHO criteria) or ≥140/90mmHg or self-reported use of antihypertensive medication (Joint National Committee on Prevention, Detection, Evaluation, and Treatment’s report (JNC 7 criteria))7,8 When information needed to consider eligibility was missing the study was excluded.

Hypertension detection was defined as any prior diagnosis of hypertension made by a health professional among the population defined as having hypertension. Treatment of hypertension was defined as use of recognized antihypertensive medication among the population defined as having hypertension, whereas control of hypertension was defined as blood pressure of <140/90mmHg among the population defined as having hypertension. Comparisons were made only between studies that had used the same definitions. Using the “Statcalc” function of EPI INFO (Version 6, Center for Disease Control, USA), it was determined that a sample size of 400 was adequate to detect prevalence of hypertension between 10% to 50% with 5% precision and 95% confidence. Data were extracted after a standard protocol and using standard data collection forms and checklist by a single reviewer (J.A.) with uncertainties resolved by discussion with the other authors. Data on year of survey, country of study, age of participants, sampling methods, response rate, sample size, methods for preparation, and measurement of blood pressure, definition(s) used for hypertension, and type of measuring device used were extracted. Prevalence of hypertension (unadjusted and age adjusted if stated), percentage of those with hypertension who had been previously diagnosed, on treatment, and those controlled were also obtained. We described the population used for the standardization of hypertension prevalence where this information was available. Where information was available, the prevalence was obtained by age, gender, socio-economic status, and rural-urban residence. Multiple papers from a study were included if these were found and consistency of results checked for the same study.

A formal meta-analysis was not conducted because of the heterogeneity in methods used and participants involved.

Results

The initial search identified 1037 references. An additional 28 references were found from reference lists of articles and 5 more from the World Health Organization database. Figure 1 summarizes the selection process for the total of 1070 publications. In all 37 publications describing 25 studies from 10 countries in SSA satisfied the criteria for inclusion.9–45 The list of excluded articles and reasons for exclusion are in the data supplement available online at http://hyper.ahajournals.org.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Summary of literature search.

Papers identified from the same study were grouped together and compared for consistency. The number of participants involved in the studies ranged from 446 to 13 802. The mercury sphygmomanometer was used for measurement of blood pressure in 14 studies and an electronic monitor used in 9 studies. The majority of studies used blood pressure measured on a single visit. With the exception of 2 studies, blood pressure was measured at least twice per visit and an average value determined in most cases. Three studies that sampled from whole national populations were identified with one reporting results for urban and rural areas separately. Apart from the national studies, 10 studies included both rural and urban participants with 5 of those reporting age-standardized prevalence of hypertension for rural and urban populations separately. Urban and rural communities had been defined in the studies by each country’s prior enumeration of areas. Where nomadic participants were included this was stated. In studies reporting age-standardized prevalence of hypertension, prevalence had been adjusted to the age distribution of the entire study sample, the national population, or the new WHO Standard World Population.46 A summary of the characteristics of the studies and methods used in blood pressure measurements are presented in the data supplement.

Prevalence of Hypertension

The Table shows crude and age-adjusted prevalence of hypertension defined by both WHO and JNC 7 criteria for each study. The prevalence of hypertension varied extensively between and within studies. The difference in the prevalence of hypertension between males and females was minimal for almost all communities. When studies with both urban and rural populations were examined, prevalence of hypertension was observed to be higher in the urban compared with the rural population as shown in Figure 2. A study from rural Tanzania that had sampled from 3 rural regions and reported prevalence separately showed prevalence to be lowest for both females and males in the rural region described as least advantaged, and highest in that described as the most socially and economically advantaged.39

View this table:
  • View inline
  • View popup

Table. Prevalence of Hypertension in Sub-Saharan Africa

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Age-standardized prevalence of hypertension by gender and area of residence. Hypertension is defined as BP ≥160/95 mm Hg. M represents males and F females.

Figures 3 and 4⇓ show the age- and sex-specific prevalence of hypertension defined by both WHO and JNC 7 criteria. The prevalence of hypertension defined by both criteria was observed to increase steadily from the youngest to the highest age groups. This was generally similar for males and females and in rural and urban studies. In a study from rural Tanzania involving 3 rural populations, however, there was an increase in only the population described as advantaged with virtually no increase with age in the other 2.39

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Age specific prevalence of hypertension by gender. Hypertension is defined as blood pressure ≥140/90 mm Hg. Age group 55+ in study 3 was excluded because of small numbers.

Figure4
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 4. Age-specific prevalence of hypertension by gender. Hypertension is defined as blood pressure ≥160/95 mm Hg. Age group 55+ in study 3 is excluded because of small numbers.

Temporal trends in blood pressure prevalence could not be established conclusively from the data available because few studies had been done in which serial surveys using the same methodology had been conducted. One exception was a study from Tanzania involving urban, rural, and seminomadic participants aged 47 to 57 years. An initial survey was conducted in 1987 and a resurvey in 1998 in the same areas using similar methods. There was a marked increase over the period with overall prevalence increasing from 25.4% in men to 41.1% and from 27.2% to 38.7% in women. The increase was observed for rural and urban as well as seminomadic participants.30,31

With hypertension defined as BP ≥140/90 mm Hg, the level of hypertension detection ranged between 11% in all participants in rural Cameroon26 and 47% in females in South Africa,38 treatment between 10% in urban Cameroon17 and 32% in Ghana,10 and control between 0.4% and 16.8%.17,38 Females were more likely to have been detected, be on treatment, and have hypertension controlled compared with males. A one-year follow-up of newly diagnosed hypertensive in 1 study showed that despite referral, 62.9% had uncontrolled hypertension and 26.8% claimed to be unaware of their hypertension.16,28

Discussion

There have been a surprisingly large number of studies that provide data about hypertension in SSA, but very few of these provide age-standardized data which allow comparability between studies. The individual studies show a generally high prevalence of hypertension. Urban populations consistently had higher prevalence of hypertension compared with their rural counterparts in almost all studies that covered both types of area. The prevalence of hypertension increased with age. For most studies hypertension was defined on the basis of blood pressure taken on one visit only and thus may have overestimated the prevalence. There was very little information on temporal trends in the prevalence of hypertension because studies undertaken at different time periods were among different populations or did not use similar methods. There were generally low levels of detection, treatment, and control of hypertension.

This review used a wide ranging search strategy and a standard protocol to determine which studies to include and to extract data making conclusions more reliable and limiting bias.47 There were great variations in the studies reviewed, partly because of the criteria used in selecting participants and also methods applied in measurement and classification of blood pressure. Variations in the age structure of the different populations included in our review limited the ability to compare results directly. Different standard populations had also been used in most studies that reported age-standardized values, and data available did not allow us to restandardize using the same reference population thus limiting comparability between studies greatly. Studies were included based on the extent to which the methods used were likely to give results which were representative of the population from which samples were drawn. To achieve this, studies were included only if the response rate had been mentioned and was at least 70% and sample size was reasonably large (400 participants). Studies were limited to those involving blacks only, to allow comparison among the same racial group because hypertension and its sequelae have been suggested to occur differently in blacks compared with whites living elsewhere.48–50 We included only studies that had used and documented standard blood pressure measuring protocol. Urban and rural contrasts involved age standardized prevalence that used the same approach within a single study. The various differences between the studies meant that meta-analysis was not appropriate.

The higher prevalence of hypertension in urban areas compared with rural areas strongly implicates differences in lifestyle as an explanatory factor. Higher levels of obesity and increased salt and fat intake from consuming more processed foods and engaging in jobs with minimal physical activity are likely explanations for higher hypertension in urban populations.

The prevalence of hypertension in SSA, particularly in urban areas, was as high as that from most countries in established market economies48,49 with lower detection, treatment, and control levels reported from SSA.49,50 Contrary to reports from the USA and Europe of higher prevalence of hypertension in rural areas,50–53 prevalence of hypertension was higher in urban compared with rural areas in SSA.

Women were reported to have better detection, treatment, and control rates than men in both SSA and high income countries. A possible explanation for higher detection among women is the increased chances of having blood pressure measured on contact with a health facility which usually occurs with pregnancy and related health conditions. Women probably accept more readily the diagnosis of hypertension even in the absence of symptoms and recognizing the need to stay healthy to support their families, are more willing to comply with treatment and get controlled. The generally low levels of detection, treatment, and control of hypertension reported emphasizes the difficulty in managing chronic health conditions that are usually not associated with symptoms and yet need life long management to ensure control. In SSA where resources for health are generally limited and individuals and households usually have to pay for the utilization of services and treatment, it is very likely that health conditions such as hypertension will receive little attention. A few programs have been established in SSA over the years for the effective control of hypertension.54–57 The reports from one of these programs indicate that even though targeted objectives were not reached because of many problems encountered, the project increased public awareness of the problem of hypertension.55,56 It is interesting to note that 1 year after diagnosing participants in 1 study and referring them to a health facility for treatment, almost 27% claimed to be unaware of having hypertension.16,28 Was this because the information given was inadequate and misunderstood or were the affected in a state of denial?

Perspectives

In spite of the relatively limited evidence base, it is clear that hypertension is a major public health problem in SSA, particularly in urban areas. Levels of detection, treatment, and control are worryingly low, suggesting that high levels of adverse effects such as stroke, heart failure, and renal failure will become apparent in the years to come. There is an urgent need to encourage healthy lifestyles as a means of primary prevention and also to increase awareness of hypertension through public education. Treatment efforts need to be intensified to control existing hypertension better and reduce future health risks. Explanations for the marked rural-urban difference in prevalence would be of great interest, particularly because they may provide clues to the drivers of the increasing risk of cardiovascular disease among urban populations in SSA and other low income settings. Specific issues include the possible role of migration and the characteristics of the urban lifestyle or environment that most strongly predict hypertension. There is also a need to identify barriers to treatment and good control of hypertension and how these could be improved. There is an urgent need to put in place mechanisms of gathering accurate and complete data about blood pressure among populations in SSA, particularly on time-trends. In the absence of such information, projections on the burden of hypertension in SSA will be limited, reliant on predicted demographic patterns with little or no account of the many other major drivers of health at a time when many communities in SSA are undergoing major changes.

Acknowledgments

Sources of Funding

This review forms part of research work towards a PhD (J.A.) at the London School of Hygiene and Tropical Medicine, funded by the Commonwealth Scholarship Commission. The sponsor had no role in study design, data collection, analysis, interpretation, or writing of the report.

Disclosures

None.

  • Received May 1, 2007.
  • Revision received May 25, 2007.
  • Accepted September 7, 2007.

References

  1. ↵
    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Measuring the Global Burden of Disease and risk Factors, 1990–2001. Global Burden of Disease and Risk Factors. 2006. Available at: http://www.dcp2.org/pubs/GBD. Accessed March 5, 2006.
  2. ↵
    Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006; 24: 423–430.
    OpenUrlCrossRefPubMed
  3. ↵
    Seedat YK. Recommendations for hypertension in sub-Saharan Africa. Cardiovasc J S Afr. 2004; 15: 157–158.
    OpenUrlPubMed
  4. ↵
    Khor GL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Pac J Clin Nutr. 2001; 10: 76–80.
    OpenUrlCrossRefPubMed
  5. ↵
    Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr. 2002; 5: 239–243.
    OpenUrlCrossRefPubMed
  6. ↵
    WHO Collaborating Centre for Surveillance of Cardiovascular Disease. Epidemiological profiles of cardiovascular and cerebrovascular diseases in the world. Global Cardiovascular Infobase. 2006. Available at: http://cvdinfobase.ca/. Accessed May 29, 2006.
  7. ↵
    WHO Expert Committee. Arterial Hypertension (Technical report Series No. 628). Geneva: World Health Organisation, 1978.
  8. ↵
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–1252.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Agyemang C. Rural and urban differences in blood pressure and hypertension in Ghana, West Africa. Public Health. 2006; 120: 525–533.
    OpenUrlCrossRefPubMed
  10. ↵
    Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006; 20: 67–71.
    OpenUrlCrossRefPubMed
  11. ↵
    Amoah AG. Hypertension in Ghana: a cross-sectional community prevalence study in greater Accra. Ethn Dis. 2003; 13: 310–315.
    OpenUrlPubMed
  12. ↵
    Astagneau P, Lang T, Delarocque E, Jeannee E, Salem G. Arterial hypertension in urban Africa: an epidemiological study on a representative sample of Dakar inhabitants in Senegal. J Hypertens. 1992; 10: 1095–1101.
    OpenUrlPubMed
  13. ↵
    Bunker CH, Ukoli FA, Matthews KA, Kriska AM, Huston SL, Kuller LH. Weight threshold and blood pressure in a lean black population. Hypertension. 1995; 26: 616–623.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, Forrester T, Bennett F, Wilks R. The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997; 87: 160–168.
    OpenUrlCrossRefPubMed
  15. ↵
    Cruickshank JK, Mbanya JC, Wilks R, Balkau B, Forrester T, Anderson SG, Mennen L, Forhan A, Riste L, McFarlane-Anderson N. Hypertension in four African-origin populations: current ‘Rule of Halves’, quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens. 2001; 19: 41–46.
    OpenUrlCrossRefPubMed
  16. ↵
    Daniels A, Hoffman M, Lombard C, Steyn K, Levitt N, Katzenellenbogen J. Blood pressure and social support observations from Mamre, South Africa, during social and political transition. J Hum Hypertens. 1999; 13: 689–693.
    OpenUrlCrossRefPubMed
  17. ↵
    Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, Aspray TJ, Alberti KG. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000; 18: 145–152.
    OpenUrlCrossRefPubMed
  18. ↵
    Ekpo EB, Udofia O, Eshiet NF, Andy JJ. Demographic, life style and anthropometric correlates of blood pressure of Nigerian urban civil servants, factory and plantation workers. J Hum Hypertens. 1992; 6: 275–280.
    OpenUrlPubMed
  19. ↵
    Elbagir M, Ahmed K. Blood pressure in a multiracial urban Sudanese community. J Hum Hypertens. 1990; 4: 621–624.
    OpenUrlPubMed
  20. ↵
    Forrest KY, Bunker CH, Kriska AM, Ukoli FA, Huston SL, Markovic N. Physical activity and cardiovascular risk factors in a developing population. Med Sci Sports Exerc. 2001; 33: 1598–1604.
    OpenUrl
  21. ↵
    Giles WH, Pacque M, Greene BM, Taylor HR, Munoz B, Cutler M, Douglas J. Prevalence of hypertension in rural west Africa. Am J Med Sci. 1994; 308: 271–275.
    OpenUrlPubMed
  22. ↵
    Kadiri S, Walker O, Salako BL, Akinkugbe O. Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens. 1999; 13: 23–27.
    OpenUrlCrossRefPubMed
  23. ↵
    Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens. 2006; 20: 91–92.
    OpenUrlCrossRefPubMed
  24. ↵
    Lang T, Pariente P, Salem G, Tap D. Social, professional conditions and arterial hypertension: an epidemiological study in Dakar, Senegal. J Hypertens. 1988; 6: 271–276.
    OpenUrlPubMed
  25. ↵
    Markovic N, Olomu IN, Bunker CH, Huston SL, Ukoli FA, Kuller LH. Adequacy of a single visit for classification of hypertensive status in a Nigerian civil servant population. Int J Epidemiol. 1994; 23: 723–729.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Mbanya JC, Minkoulou EM, Salah JN, Balkau B. The prevalence of hypertension in rural and urban Cameroon. Int J Epidemiol. 1998; 27: 181–185.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Mennen LI, Mbanya JC, Cade J, Balkau B, Sharma S, Chungong S, Cruickshank JK. The habitual diet in rural and urban Cameroon. Eur J Clin Nutr. 2000; 54: 150–154.
    OpenUrlCrossRefPubMed
  28. ↵
    Metcalf CA, Hoffman MN, Steyn K, Katzenellenbogen JM, Fourie JM. Design and baseline characteristics of a hypertension intervention program in a South African village. J Hum Hypertens. 1996; 10: 21–26.
    OpenUrlPubMed
  29. ↵
    Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A. The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006; 20: 59–65.
    OpenUrlCrossRefPubMed
  30. ↵
    Njelekela M, Negishi H, Nara Y, Tomohiro M, Kuga S, Noguchi T, Kanda T, Yamori M, Mashalla Y, Jian Liu L, Mtabaji J, Ikeda K, Yamori Y. Cardiovascular risk factors in Tanzania: a revisit. Acta Trop. 2001; 79: 231–239.
    OpenUrlCrossRefPubMed
  31. ↵
    Njelekela M, Sato T, Nara Y, Miki T, Kuga S, Noguchi T, Kanda T, Yamori M, Ntogwisangu J, Masesa Z, Mashalla Y, Mtabaji J, Yamori Y. Nutritional variation and cardiovascular risk factors in Tanzania–rural-urban difference. S Afr Med J. 2003; 93: 295–299.
    OpenUrlPubMed
  32. ↵
    Okosun IS, Cooper RS, Rotimi CN, Osotimehin B, Forrester T. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans. Diabetes Care. 1998; 21: 1836–1842.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Okosun IS, Forrester TE, Rotimi CN, Osotimehin BO, Muna WF, Cooper RS. Abdominal adiposity in six populations of West African descent: prevalence and population attributable fraction of hypertension. Obes Res. 1999; 7: 453–462.
    OpenUrlPubMed
  34. ↵
    Okosun IS, Rotimi CN, Forrester TE, Fraser H, Osotimehin B, Muna WF, Cooper RS. Predictive value of abdominal obesity cut-off points for hypertension in blacks from west African and Caribbean island nations. Int J Obes Relat Metab Disord. 2000; 24: 180–186.
    OpenUrlCrossRefPubMed
  35. ↵
    Olatunbosun ST, Kaufman JS, Cooper RS, Bella AF. Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. J Hum Hypertens. 2000; 14: 249–257.
    OpenUrlCrossRefPubMed
  36. ↵
    Sobngwi E, Mbanya JC, Unwin NC, Kengne AP, Fezeu L, Minkoulou EM, Aspray TJ, Alberti KG. Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord. 2002; 26: 1009–1016.
    OpenUrlCrossRefPubMed
  37. ↵
    Sobngwi E, Mbanya JC, Unwin NC, Porcher R, Kengne AP, Fezeu L, Minkoulou EM, Tournoux C, Gautier JF, Aspray TJ, Alberti K. Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Int J Epidemiol. 2004; 33: 769–776.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J Hypertens in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens. 2001; 19: 1717–1725.
    OpenUrlCrossRefPubMed
  39. ↵
    Swai AB, McLarty DG, Kitange HM, Kilima PM, Tatalla S, Keen N, Chuwa LM, Alberti KG. Low prevalence of risk factors for coronary heart disease in rural Tanzania. Int J Epidemiol. 1993; 22: 651–659.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    van der Sande MA, Bailey R, Faal H, Banya WA, Dolin P, Nyan OA, Ceesay SM, Walraven GE, Johnson GJ, McAdam KP. Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health. 1997; 2: 1039–1048.
    OpenUrlCrossRefPubMed
  41. ↵
    van der Sande MA, Ceesay SM, Milligan PJ, Nyan OA, Banya WA, Prentice A, McAdam KP, Walraven GE. Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities. Am J Public Health. 2001; 91: 1641–1644.
    OpenUrlPubMed
  42. ↵
    van der Sande MA, Milligan PJ, Nyan OA, Rowley JT, Banya WA, Ceesay SM, Dolmans WM, Thien T, McAdam KP, Walraven GE. Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens. 2000; 14: 489–496.
    OpenUrlCrossRefPubMed
  43. ↵
    van der Sande MA, Milligan PJ, Walraven GE, Dolmans WM, Newport M, Nyan OA, Banya WA, Thien T, Ward R, McAdam KP. Geographical variation in prevalence of hypertension within The Gambia. J Hum Hypertens. 2001; 15: 733–739.
    OpenUrlCrossRefPubMed
  44. ↵
    van der Sande MA, Walraven GE, Milligan PJ, Banya WA, Ceesay SM, Nyan OA, McAdam KP. Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bull World Health Organ. 2001; 79: 321–328.
    OpenUrlPubMed
  45. ↵
    Vaughan JP. Blood pressure and heart murmurs in a rural population in the United Republic of Tanzania. Bull World Health Organ. 1979; 57: 89–97.
    OpenUrlPubMed
  46. ↵
    Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M Age standardization of rates: a new WHO standard. Global Programme on Evidence for Health Policy Discussion Paper Series: no. 31. World Health Organization. Geneva, 2000.
  47. ↵
    Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Cmaj. 1988; 138: 697–703.
    OpenUrlAbstract
  48. ↵
    Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217–223.
    OpenUrlCrossRefPubMed
  49. ↵
    Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004; 43: 10–17.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998; 32: 998–1002.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Joyce Fan Z, Lackland DT, Lipsitz SR, Nicholas JS, Egan BM, Tim Garvey W, Hutchison FN. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007; 13: 179–187.
    OpenUrlCrossRefPubMed
  52. ↵
    Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol. 2004; 33: 1345–1352.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Mainous AG 3rd, King DE, Garr DR, Pearson WS. Race, rural residence, and control of diabetes and hypertension. Ann Fam Med. 2004; 2: 563–568.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Oyediran ABCR, Bademos O, Olatunde IA. Community control of hypertension. Nigerian Med J. 1976; 6: 248–253.
    OpenUrl
  55. ↵
    Pobee JO. Community-based high blood pressure programs in sub-Saharan Africa. Ethn Dis. 1993; 3 Suppl: S38–45.
    OpenUrlPubMed
  56. ↵
    Pobee JOM. Epidemiological report from West Africa. In Gross F, Strasser T, ed. Mild Hypertension: Recent Advances. New York, Raven Press; 1983: 33–53.
  57. ↵
    Unwin N, Mugusi F, Aspray T, Whiting D, Edwards R, Mbanya JC, Sobgnwi E, Rashid S, Alberti KG. Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health. 1999; 113: 141–146.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
December 2007, Volume 50, Issue 6
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Hypertension In Sub-Saharan Africa
    Juliet Addo, Liam Smeeth and David A. Leon
    Hypertension. 2007;50:1012-1018, originally published November 20, 2007
    https://doi.org/10.1161/HYPERTENSIONAHA.107.093336

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Hypertension In Sub-Saharan Africa
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Hypertension In Sub-Saharan Africa
    Juliet Addo, Liam Smeeth and David A. Leon
    Hypertension. 2007;50:1012-1018, originally published November 20, 2007
    https://doi.org/10.1161/HYPERTENSIONAHA.107.093336
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension
  • Epidemiology, Lifestyle, and Prevention
    • Epidemiology

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured